Drug Week
Susan Hasty, Publisher
Table of Contents . . . December 6th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Drug Week | Other Publications
Chemotherapy-induced Febrile Neutropenia - New data confirm the impact of once-per-cycle pegfilgrastim for neutropenia
HIV/AIDS Therapy - Gabexate mesilate, octreotide effective for pancreatic conditions
Chronic Kidney Disease - BMP-7 may prevent bone and vascular complications
Congenital Heart Disease - Phase III study shows Synagis reduces RSV hospitalization
Erectile Dysfunction - Spontaneous sex still possible despite Viagra's 1-hour delayed action
Rheumatoid Arthritis - New data demonstrate safety and efficacy of leflunomide
Ulcerative Colitis - Infliximab may induce clinical remission, reduce need for steroid use
Alpha Interferon - Schering-Plough settles royalty payment arbitrations
Alzheimer Disease - Thuris enters feasibility collaboration to test RapidAging
Asthma - Disease costs are driven by medications, work loss
Cancer Therapy - Company wins patent to protect lead compound, NC381
Cancer Therapy - Study: Tumor regression occurs after injection of DNA complex
Cardiovascular Diseases - Company gets IND for phase II trials with NCX 4016
Contraception - Ortho Tri-Cyclen Lo now available by prescription
Drug Complications - NCL launches campaign to educate about dangers of OTC pain medications
Drug Trends - Analysis: Company hopes to find growth in depression market with duloxetine
Duodenal Ulcers - Genpharm wins FDA tentative approval for omeprazole
Financing - Pharmion completes $40 million private placement
HIV/AIDS Therapy - Alternative therapy use may signal psychological, emotional problems
Heart Failure - Valsartan improves survival, reduces hospitalizations in HF patients not taking ACE inhibitors
Hepatitis C - Interim results of phase I Albuferon-alpha clinical trial promising
Hepatitis C - Pharmaceutical group identifies new class of CpG oligonucleotides
Hepatocellular Carcinoma - New evidence disfavors tamoxifen for primary liver cancer
Hormone Replacement Therapy - Halting HRT: Treatment alternatives and market impact
Infectious Disease - International distribution agreements inked for Nabi-HB, hepatitis B antibody product
Infectious Disease Therapy - Amikacin enhances rifampin activity against Mycobacterium ulcerans
Kidney Disease - Study: Fosrenol reduces hypercalcemia risk in end stage renal disease
Legal Issues - Court upholds Merck's patent for osteoporosis drug
Medication Safety - Drug-induced ocular side effects are wide ranging
Metastatic Breast Cancer - Paclitaxel-based chemotherapy increases survival by 31%
Metastatic Breast Cancer - Phase II trial of Navelbine plus Herceptin for HER2 looks promising
Regulatory Issues - Study calls for more testing of drugs in children
Schistosomiasis - Study points to dexamethasone as possible treatment adjuvant
Traumatic Brain Injury - Investigational new drug application filed for phase III study of dexanabinol
Tuberculosis Therapy - High relapse rate seen after "successful" drug-resistant TB treatment
Tuberculosis Therapy - SRL172 ineffective as treatment adjunct for HIV coinfected patients
Ventricular Fibrillation - Company adds new cardiology medication to its product line
Ventricular Fibrillation - FDA denies pediatric exclusivity for Cordarone I.V.
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
